To the full analysis
Buyback calculator for CareDx
CareDx stock: key metrics
CDNACareDx had an operating margin of −6.6% and a return on invested capital (ROIC) of −13.3% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2012 | 61.2% | −11.5% | −24.7% |
| 2013 | 58.9% | −3.9% | −16.0% |
| 2014 | 68.7% | 4.6% | 2.9% |
| 2015 | 63.5% | −42.4% | −48.7% |
| 2016 | 48.0% | −91.9% | −97.1% |
| 2017 | 55.8% | −42.0% | −114.8% |
| 2018 | 56.9% | −20.3% | −61.1% |
| 2019 | 64.2% | −19.3% | −17.3% |
| 2020 | 67.2% | −11.7% | −9.7% |
| 2021 | 67.1% | −10.0% | −10.3% |
| 2022 | 65.1% | −24.0% | −23.8% |
| 2023 | 63.6% | −72.5% | −67.9% |
| 2024 | 67.2% | 12.2% | 15.7% |
| 2025 | 67.6% | −6.6% | −5.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2012 | 3.4% | −37.8% | −51.2% |
| 2013 | 2.4% | −11.6% | −35.9% |
| 2014 | 1.9% | 3.1% | 1.3% |
| 2015 | −46.5% | −59.6% | −24.6% |
| 2016 | −100.0% | −55.1% | −51.4% |
| 2017 | 200.0% | −85.1% | −66.4% |
| 2018 | −48.7% | −57.7% | −35.8% |
| 2019 | −22.2% | −39.7% | −14.5% |
| 2020 | −6.7% | −25.9% | −5.1% |
| 2021 | −6.6% | −22.4% | −5.4% |
| 2022 | −17.8% | −38.7% | −14.1% |
| 2023 | −72.8% | −37.5% | −40.8% |
| 2024 | 13.9% | 39.3% | 10.7% |
| 2025 | −7.0% | −13.3% | −5.2% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Jul 2026)
- Valuation signal Overvalued since 8 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.